Teriparatide Induced Delayed Persistent Hypercalcemia

Teriparatide, a recombinant PTH, is an anabolic treatment for osteoporosis that increases bone density. Transient hypercalcemia is a reported side effect of teriparatide that is seen few hours following administration of teriparatide and resolves usually within 16 hours of drug administration. Persi...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiruchelvam, Nirosshan, Randhawa, Jaskirat, Sadiek, Happy, Kistangari, Gaurav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151495/
https://www.ncbi.nlm.nih.gov/pubmed/25202461
http://dx.doi.org/10.1155/2014/802473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151495/
https://www.ncbi.nlm.nih.gov/pubmed/25202461
http://dx.doi.org/10.1155/2014/802473

Ejemplares similares